The stock which debuted at Rs 209.80, down 3.76 per cent, finally ended at Rs 170.95, reflecting a sharp fall of 21.58 per cent on the BSE. Intra-day, it plummeted 22.47 per cent to Rs 169.
At NSE, shares of the company nosedived 21.55 per cent to close at Rs 171.
The extreme weakness in the stock came despite a strong broader market where the Sensex zoomed 438.12 points to end at 25,338.58.
At present, the company commands a market valuation of Rs 1,454.37 crore.
Also Read
HCG was the fourth company after Precision Camshafts, TeamLease Services and Quick Heal Technologies to come out with an IPO this year.
The Rs 650-crore offer of HealthCare Global which was open from March 16-18, was oversubscribed 1.56 times.
The company had fixed the price band at Rs 205-218 for the IPO.
Kotak Mahindra Capital Company, Edelweiss Financial Services, Goldman Sachs (India) Securities, IDFC Securities, IIFL Holdings and Yes Bank were the book running lead managers to the issue.
HCG has 14 comprehensive cancer-care centres.